These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33446523)

  • 1. Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort.
    Rebelos E; Bucci M; Karjalainen T; Oikonen V; Bertoldo A; Hannukainen JC; Virtanen KA; Latva-Rasku A; Hirvonen J; Heinonen I; Parkkola R; Laakso M; Ferrannini E; Iozzo P; Nummenmaa L; Nuutila P
    Diabetes Care; 2021 Mar; 44(3):788-794. PubMed ID: 33446523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity risk is associated with brain glucose uptake and insulin resistance.
    Pekkarinen L; Kantonen T; Rebelos E; Latva-Rasku A; Dadson P; Karjalainen T; Bucci M; Kalliokoski K; Laitinen K; Houttu N; Kirjavainen AK; Rajander J; Rönnemaa T; Nummenmaa L; Nuutila P
    Eur J Endocrinol; 2022 Dec; 187(6):917-928. PubMed ID: 36288097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Obesity Risk SNP (rs17782313) near the MC4R Gene Is Not Associated with Brain Glucose Uptake during Insulin Clamp-A Study in Finns.
    Rebelos E; Honka MJ; Ekblad L; Bucci M; Hannukainen JC; Fernandes Silva L; Virtanen KA; Nummenmaa L; Nuutila P
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33806715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain substrate metabolism and ß-cell function in humans: A positron emission tomography study.
    Rebelos E; Mari A; Bucci M; Honka MJ; Hannukainen JC; Virtanen KA; Hirvonen J; Nummenmaa L; Heni M; Iozzo P; Ferrannini E; Nuutila P
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00136. PubMed ID: 32704559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow-up.
    Rebelos E; Immonen H; Bucci M; Hannukainen JC; Nummenmaa L; Honka MJ; Soinio M; Salminen P; Ferrannini E; Iozzo P; Nuutila P
    Diabetes Obes Metab; 2019 Feb; 21(2):218-226. PubMed ID: 30098134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different establishing conditions of hyperinsulinemic-euglycemic clamp technique among different groups].
    Yang G; Li CL; Tian H; Cheng SW; Li YJ; Cheng XL; Fang FS
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2410-4. PubMed ID: 23158664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
    Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
    Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: whole-body PET/MRI during hyperinsulinemia.
    Eriksson JW; Visvanathar R; Kullberg J; Strand R; Skrtic S; Ekström S; Lubberink M; Lundqvist MH; Katsogiannos P; Pereira MJ; Ahlström H
    Eur J Endocrinol; 2021 May; 184(6):879-889. PubMed ID: 33852422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats.
    Morita I; Tanimoto K; Akiyama N; Naya N; Fujieda K; Iwasaki T; Yukioka H
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E264-E272. PubMed ID: 28143857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study.
    Boersma GJ; Johansson E; Pereira MJ; Heurling K; Skrtic S; Lau J; Katsogiannos P; Panagiotou G; Lubberink M; Kullberg J; Ahlström H; Eriksson JW
    Horm Metab Res; 2018 Aug; 50(8):627-639. PubMed ID: 30001566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo insulin responsiveness for glucose uptake and production at eu- and hyperglycemic levels in normal and diabetic rats.
    Koopmans SJ; Maassen JA; Radder JK; Frölich M; Krans HM
    Biochim Biophys Acta; 1992 Jan; 1115(3):230-8. PubMed ID: 1739737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
    Williams KV; Bertoldo A; Kinahan P; Cobelli C; Kelley DE
    Diabetes; 2003 Jul; 52(7):1619-26. PubMed ID: 12829624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an early decline in baseline plasma glucose concentration after acute insulin elevation during euglycemic hyperinsulinemic clamp in patients with type 2 diabetes mellitus.
    Wasada T; Kuroki H; Arii H; Sato A; Katsumori K; Saito S; Iwamoto Y
    Endocr J; 2000 Jun; 47(3):309-16. PubMed ID: 11036875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the [13C]glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance.
    Lewanczuk RZ; Paty BW; Toth EL
    Diabetes Care; 2004 Feb; 27(2):441-7. PubMed ID: 14747226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Honka MJ; Latva-Rasku A; Bucci M; Virtanen KA; Hannukainen JC; Kalliokoski KK; Nuutila P
    Eur J Endocrinol; 2018 May; 178(5):523-531. PubMed ID: 29535167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-stimulated brain glucose uptake correlates with brain metabolites in severe obesity: A combined neuroimaging study.
    Rebelos E; Latva-Rasku A; Koskensalo K; Pekkarinen L; Saukko E; Ihalainen J; Honka MJ; Tuisku J; Bucci M; Laurila S; Rajander J; Salminen P; Nummenmaa L; Jansen JF; Ferrannini E; Nuutila P
    J Cereb Blood Flow Metab; 2024 Mar; 44(3):407-418. PubMed ID: 37824728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.
    Donga E; Dekkers OM; Corssmit EP; Romijn JA
    Eur J Endocrinol; 2015 Jul; 173(1):101-9. PubMed ID: 25899581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.